What is Novavax's restricted cash?

Novavax (NVAX) reported restricted cash of $0 in Q1 2026.

How has Novavax's restricted cash changed year-over-year?

Novavax's restricted cash decreased by 100.0% year-over-year, from $10.68M to $0.

What is the long-term trend for Novavax's restricted cash?

Over 5 years (2020 to 2025), Novavax's restricted cash has grown at a -35.0% compound annual growth rate (CAGR), from $93.88M to $10.88M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Novavax NVAX Restricted Cash

Restricted Cash at other companies

Merck & Co.MRK

$71M-31.1%

Vaxcyte, Inc.PCVX

$1.47M+11.1%

ALN

Alnylam PharmaceuticalsALNY

$1.64M-36.8%

ModernaMRNA

——

Roivant SciencesROIV

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's restricted cash?: Novavax (NVAX) reported restricted cash of $0 in Q1 2026.
How has Novavax's restricted cash changed year-over-year?: Novavax's restricted cash decreased by 100.0% year-over-year, from $10.68M to $0.
What is the long-term trend for Novavax's restricted cash?: Over 5 years (2020 to 2025), Novavax's restricted cash has grown at a -35.0% compound annual growth rate (CAGR), from $93.88M to $10.88M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.